Controversies in the 2017 ACC/AHA hypertension guidelines: Who can be eligible for treatments under the new guidelines?: An asian perspective

16Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Until the 2017 ACC/AHA Hypertension Guidelines were released, the target blood pressure (BP) for adults with hypertension (HTN) was 140/90 mmHg in most of the guidelines. The new 2018 ESC/ESH, Canadian, Korean, Japan, and Latin American hypertension guidelines have maintained the <140/90 mmHg for the primary target in the general population and encourage reduction to <130/80 if higher risk. This is more in keeping with the 2018 American Diabetes Association guidelines. However, the 2017 ACC/AHA guidelines classify HTN as BP ≥130/80 mmHg and generally recommend target BP levels below 130/80 mmHg for hypertensive patients independently of comorbid disease or age. Although the new guidelines mean that more people (nearly 50% of adults) will be diagnosed with HTN, the cornerstone of therapy is still lifestyle management unless BP cannot be lowered to this level; thus, more people will require BP-lowering medications. To date, there have been many controversies about the definition of HTN and the target BP. Targeting an intensive systolic BP goal can increase the adverse effects of multiple medications and the cardiovascular disease risk by excessively lowering diastolic BP, especially in patients with high risk, including those with diabetes, chronic kidney disease, heart failure, and coronary artery disease, and the elderly. In this review, we discuss these issues, particularly regarding the optimal target BP.

References Powered by Scopus

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

11239Citations
N/AReaders
Get full text

Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies

8465Citations
N/AReaders
Get full text

2018 ESC/ESH Guidelines for themanagement of arterial hypertension

7752Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Strategies to overcome residual risk during statins era

25Citations
N/AReaders
Get full text

Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease

18Citations
N/AReaders
Get full text

Controversies in the management of patients with arterial hypertension

16Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ihm, S. H., Bakris, G., Sakuma, I., Sohn, I. S., & Koh, K. K. (2019, February 25). Controversies in the 2017 ACC/AHA hypertension guidelines: Who can be eligible for treatments under the new guidelines?: An asian perspective. Circulation Journal. Japanese Circulation Society. https://doi.org/10.1253/circj.CJ-18-1293

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

40%

Researcher 4

27%

Professor / Associate Prof. 3

20%

Lecturer / Post doc 2

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 13

65%

Biochemistry, Genetics and Molecular Bi... 3

15%

Materials Science 2

10%

Engineering 2

10%

Save time finding and organizing research with Mendeley

Sign up for free